Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.597,84
0,00%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Heron Therapeautics Inc (HRTX) Heron Therapeautics Inc (HRTX) Notizie

Heron Therapeautics Inc

HRTX
1,7699
0,1199 (7,27%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/2/202522:20PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
04/2/202523:40EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
04/2/202518:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202518:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202517:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202517:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202517:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202517:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202517:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202515:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202515:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202515:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202515:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202422:05EDGAR2Form 8-K - Current report
23/12/202422:05PRNUSHeron Therapeutics Announces Corporate Headquarters..
04/12/202414:45APSWall Street Analysts Were Busy This Morning
03/12/202423:15EDGAR2Form 8-K - Current report
03/12/202422:36PRNUSU.S. District Court Upholds Validity of CINVANTI® Patents
12/11/202414:06EDGAR2Form 8-K - Current report
12/11/202413:55PRNUSHeron Therapeutics Announces Third Quarter 2024 Financial..
06/11/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202418:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/11/202423:09EDGAR2Form 8-K - Current report
04/11/202423:00PRNUSHeron Therapeutics Announces Appointment of Michael Kaseta..
29/10/202421:05PRNUSHeron Therapeutics to Report Third Quarter 2024 Financial..
24/10/202420:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
21/10/202421:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202421:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202421:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202422:08PRNUSHeron Therapeutics Reaffirms Availability and Ample Supply..
25/9/202414:00PRNUSHeron Therapeutics Announces FDA Approval of the Prior..
03/9/202414:00PRNUSHeron Therapeutics Announces Appointment of Brett Fleshman..
06/8/202422:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/8/202422:05EDGAR2Form 8-K - Current report
06/8/202422:05PRNUSHeron Therapeutics Announces Second Quarter 2024 Financial..
30/7/202422:05PRNUSHeron Therapeutics to Report Second Quarter 2024 Financial..
22/7/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202414:00PRNUSHeron Therapeutics Announces the Inclusion of ZYNRELEF® as a..
02/7/202414:00PRNUSHeron Therapeutics Announces Acceptance of the Prior..
18/6/202422:43EDGAR2Form 8-K - Current report
17/6/202420:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:08EDGAR2Form SC 13D/A - General statement of acquisition of..
29/5/202414:05EDGAR2Form 8-K - Current report
29/5/202414:05PRNUSHeron Therapeutics Announces Prior Approval Supplement..
07/5/202414:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:05EDGAR2Form 8-K - Current report
07/5/202414:00PRNUSHeron Therapeutics Announces First Quarter 2024 Financial..
Apertura: 1,72 Min: 1,71 Max: 1,81
Chiusura: 1,65

La tua Cronologia

NASDAQ
HRTX
Heron Therapeautics
BIT
P1OWJ7
BNP Paribas Issuance
NASDAQ
FBWHX
Agf North American Divid...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci